Phase 1 Herpes Zoster Clinical Trials
9 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–9 of 9 trials
Recruiting
Phase 1Phase 2
Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population
Herpes Zoster
National Institute of Allergy and Infectious Diseases (NIAID)225 enrolled1 locationNCT05580458
Recruiting
Phase 1Phase 2
A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant
Herpes Zoster
GlaxoSmithKline184 enrolled31 locationsNCT04006808
Recruiting
Phase 1Phase 2
Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
Herpes ZostermRNA Vaccine
Sinovac Biotech Co., Ltd519 enrolled1 locationNCT07400003
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
Herpes Zoster (HZ)
Shanghai Institute Of Biological Products645 enrolled1 locationNCT06932523
Recruiting
Phase 1Phase 2
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
vaccine preventable diseasesHerpes ZosterShingles
Dynavax Technologies Corporation764 enrolled13 locationsNCT06569823
Recruiting
Phase 1
Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
Herpes Zoster (HZ)
Guangzhou Patronus Biotech Co., Ltd.92 enrolled1 locationNCT06874842
Recruiting
Phase 1
Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
vaccine preventable diseasesHerpes Zoster
CHA Vaccine Institute Co., Ltd.32 enrolled2 locationsNCT06137755
Completed
Phase 1
WNTR-VZV-001: A Phase Ib, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Tolerability of Solexan™ when Administered Topically to Acute Varicella Zoster Virus (Shingles) Lesions.
Herpes ZosterShingles
Wintermute Biomedical30 enrolled1 locationACTRN12624000075583
Not Yet Recruiting
Phase 1
Treatment of acute pain after shingles with vitamin D cream
Acute herpes zoster (shingles)
Jim Bartley10 enrolled1 locationACTRN12609001014246